DSGN
Design Therapeutics, Inc.$10.46-0.27 (-2.52%)Prev Close$10.73·MCap$694.7M·P/E—·Vol164.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
DSGN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | William Arsani | Director | Sell | 562,627 | $5.25 | $2.95M0.9% OS | 0 |
| Dec 19, 2024 | Prasad Deepa | Sell | 3,806 | $6.27 | $23.9K | 20,000 | |
| Aug 12, 2024 | William Arsani | Sell | 814,874 | $4.25 | $3.46M1.3% OS | 0Exit | |
| Mar 25, 2024 | Berger Heather A. | Buy | 1,300 | $3.74 | $4.9K | 1,300 | |
| Mar 25, 2024 | Schmid John P. | Buy | 26,965 | $3.70 | $99.7K | 26,965 | |
| Oct 2, 2023 | LAPPE RODNEY W | Director | Buy | 21,000 | $2.35 | $49.3K | 133,024 |
| Aug 30, 2023 | Prasad Deepa | Director | Buy | 12,000 | $2.31 | $27.7K | 23,806+102% |
| Aug 30, 2023 | William Arsani | Director | Buy | 2,235,000 | $2.40 | $5.37M3.6% OS | 3,000,000+292% |
| Dec 21, 2022 | Siffert Joao MD | President and CEO | Buy | 7,450 | $8.39 | $62.5K | 132,619 |
| Dec 20, 2022 | George Simeon | Director | Buy | 900,000 | $8.42 | $7.57M1.5% OS | 6,526,476 |
| Dec 12, 2022 | LAPPE RODNEY W | Director | Buy | 15,000 | $7.96 | $119.4K | 112,024 |
| Mar 22, 2022 | William Arsani | Director | Buy | 25,000 | $18.99 | $474.7K | 2,797,501 |
| Mar 22, 2022 | Xu Stella | Director | Sell | 590,880 | $19.07 | $11.27M1.0% OS | 4,168,605 |
| Sep 2, 2021 | William Arsani | Director | Buy | 40,000 | $15.45 | $618.0K | 2,772,501 |
| Apr 1, 2021 | Cormorant Asset Management, LP | Buy | 750,000 | $20.00 | $15.00M1.2% OS | 5,114,844 | |
| Apr 1, 2021 | Jeffries Sean | Chief Operating Officer | Buy | 3,050 | $20.00 | $61.0K | 3,050 |
| Apr 1, 2021 | LAPPE RODNEY W | Director | Buy | 5,000 | $20.00 | $100.0K | 97,024 |
| Apr 1, 2021 | Shah Pratik | Executive Chairperson | Buy | 25,000 | $20.00 | $500.0K | 25,000 |
| Apr 1, 2021 | SR One Capital Fund I Aggregator LP | 10% Owner | Buy | 250,000 | $20.00 | $5.00M | 5,626,476 |
| Apr 1, 2021 | Thacker Justin | Vice President, Finance | Buy | 17,500 | $20.00 | $350.0K | 17,500 |
| Apr 1, 2021 | William Arsani | Director | Buy | 700,000 | $20.00 | $14.00M1.1% OS | 2,732,501+34% |
| Apr 1, 2021 | Xu Stella | Director | Buy | 10,000 | $20.00 | $200.0K | 4,730,830 |
DSGN Insider Buying Activity
The following table shows recent insider purchases of Design Therapeutics, Inc. (DSGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | Berger Heather A. | Buy | 1,300 | $3.74 | $4.9K | 1,300 | |
| Mar 25, 2024 | Schmid John P. | Buy | 26,965 | $3.70 | $99.7K | 26,965 | |
| Oct 2, 2023 | LAPPE RODNEY W | Director | Buy | 21,000 | $2.35 | $49.3K | 133,024 |
| Aug 30, 2023 | Prasad Deepa | Director | Buy | 12,000 | $2.31 | $27.7K | 23,806+102% |
| Aug 30, 2023 | William Arsani | Director | Buy | 2,235,000 | $2.40 | $5.37M3.6% OS | 3,000,000+292% |
| Dec 21, 2022 | Siffert Joao MD | President and CEO | Buy | 7,450 | $8.39 | $62.5K | 132,619 |
| Dec 20, 2022 | George Simeon | Director | Buy | 900,000 | $8.42 | $7.57M1.5% OS | 6,526,476 |
| Dec 12, 2022 | LAPPE RODNEY W | Director | Buy | 15,000 | $7.96 | $119.4K | 112,024 |
| Mar 22, 2022 | William Arsani | Director | Buy | 25,000 | $18.99 | $474.7K | 2,797,501 |
| Sep 2, 2021 | William Arsani | Director | Buy | 40,000 | $15.45 | $618.0K | 2,772,501 |
| Apr 1, 2021 | Cormorant Asset Management, LP | Buy | 750,000 | $20.00 | $15.00M1.2% OS | 5,114,844 | |
| Apr 1, 2021 | Jeffries Sean | Chief Operating Officer | Buy | 3,050 | $20.00 | $61.0K | 3,050 |
| Apr 1, 2021 | LAPPE RODNEY W | Director | Buy | 5,000 | $20.00 | $100.0K | 97,024 |
| Apr 1, 2021 | Shah Pratik | Executive Chairperson | Buy | 25,000 | $20.00 | $500.0K | 25,000 |
| Apr 1, 2021 | SR One Capital Fund I Aggregator LP | 10% Owner | Buy | 250,000 | $20.00 | $5.00M | 5,626,476 |
| Apr 1, 2021 | Thacker Justin | Vice President, Finance | Buy | 17,500 | $20.00 | $350.0K | 17,500 |
| Apr 1, 2021 | William Arsani | Director | Buy | 700,000 | $20.00 | $14.00M1.1% OS | 2,732,501+34% |
| Apr 1, 2021 | Xu Stella | Director | Buy | 10,000 | $20.00 | $200.0K | 4,730,830 |
DSGN Insider Selling Activity
The following table shows recent insider sales of Design Therapeutics, Inc. (DSGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 13, 2025 | William Arsani | Director | Sell | 562,627 | $5.25 | $2.95M0.9% OS | 0 |
| Dec 19, 2024 | Prasad Deepa | Sell | 3,806 | $6.27 | $23.9K | 20,000 | |
| Aug 12, 2024 | William Arsani | Sell | 814,874 | $4.25 | $3.46M1.3% OS | 0Exit | |
| Mar 22, 2022 | Xu Stella | Director | Sell | 590,880 | $19.07 | $11.27M1.0% OS | 4,168,605 |
DSGN Insiders
Similar Stocks to DSGN
MRNA
Moderna, Inc.
$198.84-19.06%
$96.65B
REGN
Regeneron Pharmaceuticals, Inc.
$820.43+1.83%
$81.41B
RVMD
Revolution Medicines, Inc.
$187.77-3.35%
$38.14B
ALNY
Alnylam Pharmaceuticals, Inc.
$225.72+0.28%
$31.02B
UTHR
United Therapeutics Corporation
$584.17+3.67%
$23.76B
INCY
Incyte Corporation
$116.81+3.01%
$23.64B
INSM
Insmed Incorporated
$94.53+0.56%
$20.89B
EXEL
Exelixis, Inc.
$65.25+1.05%
$16.23B